Sumida Keiichi, Molnar Miklos Z, Potukuchi Praveen K, Thomas Fridtjof, Lu Jun Ling, Jing Jennie, Ravel Vanessa A, Soohoo Melissa, Rhee Connie M, Streja Elani, Kalantar-Zadeh Kamyar, Kovesdy Csaba P
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis.
Harold Simmons Center for Chronic Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California-Irvine, Orange.
Mayo Clin Proc. 2016 Feb;91(2):196-207. doi: 10.1016/j.mayocp.2015.10.026.
To investigate the association of estimated glomerular filtration rate (eGFR) slopes before dialysis initiation with cause-specific mortality after dialysis initiation.
In this retrospective cohort study of 18,874 US veterans who had transitioned to dialysis from October 1, 2007, through September 30, 2011, we examined the association of pre-end-stage renal disease (ESRD) eGFR slopes with all-cause, cardiovascular, and infection-related mortality during the post-ESRD period over a median follow-up of 2.0 years (interquartile range, 1.1-3.2 years). Associations were examined using Cox models with adjustment for potential confounders.
Before the 18,874 patients transitioned to dialysis, 4485 (23.8%), 5633 (29.8%), and 7942 (42.1%) experienced fast, moderate, and slow eGFR decline, respectively, and 814 (4.3%) had increasing eGFR (defined as eGFR slopes of less than -10, -10 to less than -5, -5 to <0, and ≥0 mL/min per 1.73 m(2) per year). During the study period, a total of 9744 all-cause, 2702 cardiovascular, and 604 infection-related deaths were observed. Compared with patients with slow eGFR decline, those with moderate and fast eGFR decline had a higher risk of all-cause mortality (adjusted hazard ratio [HR], 1.06; 95% CI, 1.00-1.11; and HR, 1.11; 95% CI, 1.04-1.18, respectively) and cardiovascular mortality (HR, 1.11; 95% CI, 1.01-1.23 and HR, 1.13; 95% CI, 1.00-1.27, respectively). In contrast, increasing eGFR was only associated with higher infection-related mortality (HR, 1.49; 95% CI, 1.03-2.17).
Rapid eGFR decline is associated with higher all-cause and cardiovascular mortality, and increasing eGFR is associated with higher infection-related mortality among incident dialysis cases.
探讨透析开始前估计肾小球滤过率(eGFR)斜率与透析开始后特定病因死亡率之间的关联。
在这项对2007年10月1日至2011年9月30日期间转为透析的18874名美国退伍军人的回顾性队列研究中,我们研究了终末期肾病(ESRD)前期eGFR斜率与ESRD后期全因、心血管和感染相关死亡率之间的关联,中位随访时间为2.0年(四分位间距为1.1 - 3.2年)。使用Cox模型并对潜在混杂因素进行调整来研究关联。
在这18874名患者转为透析之前,分别有4485名(23.8%)、5633名(29.8%)和7942名(42.1%)经历了快速、中度和缓慢的eGFR下降,814名(4.3%)患者的eGFR呈上升趋势(定义为eGFR斜率分别小于-10、-10至小于-5、-5至<0以及≥0 mL/(min·1.73 m²)/年)。在研究期间,共观察到9744例全因死亡、2702例心血管死亡和604例感染相关死亡。与eGFR下降缓慢的患者相比,eGFR下降中度和快速的患者全因死亡风险更高(调整后风险比[HR]分别为1.06;95%CI为1.00 - 1.11;以及HR为1.11;95%CI为1.04 - 1.18)和心血管死亡风险更高(HR分别为1.11;95%CI为1.01 - 1.23和HR为1.13;95%CI为1.00 - 1.27)。相比之下,eGFR上升仅与更高的感染相关死亡率相关(HR为1.49;95%CI为1.03 - 2.17)。
在新发病例透析中,eGFR快速下降与更高的全因和心血管死亡率相关,而eGFR上升与更高的感染相关死亡率相关。